Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 1995 Jan;99(1):87-92.

[Comparative study on frequency-doubled Nd: YAG laser, krypton laser and diode laser photocoagulation for diabetic maculopathy]

[Article in Japanese]
Affiliations
  • PMID: 7887333
Clinical Trial

[Comparative study on frequency-doubled Nd: YAG laser, krypton laser and diode laser photocoagulation for diabetic maculopathy]

[Article in Japanese]
M Okuyama et al. Nippon Ganka Gakkai Zasshi. 1995 Jan.

Abstract

Twenty six eyes of thirteen patients with diabetic maculopathy (Fukuda's classification AI, AII, BI) were treated with frequency-doubled Nd:YAG laser (6 eyes) or krypton laser (7 eyes) in one eye and diode laser (13 eyes) in the other eye. Group A was treated with frequency-doubled Nd: YAG laser and diode laser, and group B was treated with krypton laser and diode laser. The visual acuity, visual field (Octopus program 31) and fundus were examined at one month, 3 months, and 6 months after photocoagulation. Visual acuity was stable in all eyes. The central 30 degree visual sensitivity decreased more after diode laser treatment than after that of the other lasers. Krypton laser photocoagulation maintained the better visual function and was easy to use followed by frequency-doubled Nd: YAG laser. Because the appearance immediately after diode laser lesion was weaker than one hour after coagulation, it was difficult to get the proper power setting.

PubMed Disclaimer

LinkOut - more resources